[HTML][HTML] Nonalcoholic fatty liver disease, the gut microbiome, and diet
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorder in the world, yet
the pathogenesis of the disease is not well elucidated. Due to the close anatomic and …
the pathogenesis of the disease is not well elucidated. Due to the close anatomic and …
Relevant aspects of nutritional and dietary interventions in non-alcoholic fatty liver disease
MC Hernandez-Rodas, R Valenzuela… - International journal of …, 2015 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is the main cause of liver disease worldwide.
NAFLD is linked to circumstances such as type 2 diabetes, insulin resistance, obesity …
NAFLD is linked to circumstances such as type 2 diabetes, insulin resistance, obesity …
Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
F Faghihzadeh, P Adibi, R Rafiei, A Hekmatdoost - Nutrition research, 2014 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
world. Resveratrol is a polyphenolic compound with antioxidant capacity that shows …
world. Resveratrol is a polyphenolic compound with antioxidant capacity that shows …
Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial
F Mofidi, H Poustchi, Z Yari, B Nourinayyer… - British Journal of …, 2017 - cambridge.org
Although non-alcoholic fatty liver disease (NAFLD) is the leading aetiology of liver disorders
in the world, there is no proven treatment for NAFLD patients with normal or low BMI. The …
in the world, there is no proven treatment for NAFLD patients with normal or low BMI. The …
Enriching laying hens eggs by feeding diets with different fatty acid composition and antioxidants
The current study was conducted to evaluate egg quality, egg yolk fatty acids, health-related
indices and antioxidants from laying hens' eggs fed different combined vegetable by …
indices and antioxidants from laying hens' eggs fed different combined vegetable by …
The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo …
F Faghihzadeh, P Adibi, A Hekmatdoost - British Journal of Nutrition, 2015 - cambridge.org
Non-alcoholic fatty liver disease (NAFLD) is usually associated with insulin resistance,
central obesity, reduced glucose tolerance, type 2 diabetes mellitus and …
central obesity, reduced glucose tolerance, type 2 diabetes mellitus and …
[HTML][HTML] Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease
C Gelli, M Tarocchi, L Abenavoli… - World journal of …, 2017 - ncbi.nlm.nih.gov
AIM To determine the clinical effectiveness of nutritional counseling on reduction of non-
alcoholic fatty liver disease (NAFLD) severity, weight loss, metabolic and anthropometric …
alcoholic fatty liver disease (NAFLD) severity, weight loss, metabolic and anthropometric …
Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
Background The aim of the present study was to evaluate the effects of curcumin
supplementation on inflammatory indices, and hepatic features in patients with non …
supplementation on inflammatory indices, and hepatic features in patients with non …
The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver …
Background Nonalcoholic fatty liver disease (NAFLD) is a major global health problem. The
most common cause of death in these patients is due to cardiovascular disorders. The aim of …
most common cause of death in these patients is due to cardiovascular disorders. The aim of …
Randomized trial comparing effects of weight loss by liraglutide with lifestyle modification in non‐alcoholic fatty liver disease
Abstract Background & Aims We compared the effects of weight loss induced with the
glucagon‐like peptide‐1 agonist liraglutide, with that of lifestyle modification, followed by …
glucagon‐like peptide‐1 agonist liraglutide, with that of lifestyle modification, followed by …